Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.
View Top Employees from Tikva Allocell Pte LtdWebsite | https://tikvaallocell.com/ |
Employees | 18 (4 on RocketReach) |
Founded | 2023 |
Industry | Biotechnology Research |
Looking for a particular Tikva Allocell Pte Ltd employee's phone or email?
Muly Tham is the Director Research Program Management of Tikva Allocell Pte Ltd.
4 people are employed at Tikva Allocell Pte Ltd.